Search

Austin Murata

Examiner (ID: 10706, Phone: (571)270-5596 , Office: P/1712 )

Most Active Art Unit
1712
Art Unit(s)
1792, 1712
Total Applications
876
Issued Applications
484
Pending Applications
86
Abandoned Applications
318

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5648366 [patent_doc_number] => 20060134098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Immunoglobulin variable region cassette exchange' [patent_app_type] => utility [patent_app_number] => 11/282107 [patent_app_country] => US [patent_app_date] => 2005-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19006 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134098.pdf [firstpage_image] =>[orig_patent_app_number] => 11282107 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/282107
Immunoglobulin variable region cassette exchange Nov 15, 2005 Abandoned
Array ( [id] => 5614395 [patent_doc_number] => 20060116323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Tumor-inhibiting protein and the use thereof' [patent_app_type] => utility [patent_app_number] => 11/273593 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6701 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116323.pdf [firstpage_image] =>[orig_patent_app_number] => 11273593 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/273593
Tumor-inhibiting protein and the use thereof Nov 13, 2005 Abandoned
Array ( [id] => 7689533 [patent_doc_number] => 20070105165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers' [patent_app_type] => utility [patent_app_number] => 11/267948 [patent_app_country] => US [patent_app_date] => 2005-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12587 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105165.pdf [firstpage_image] =>[orig_patent_app_number] => 11267948 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/267948
Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers Nov 3, 2005 Abandoned
Array ( [id] => 5590464 [patent_doc_number] => 20060039915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'P-cadherin as a target for anti-cancer therapy' [patent_app_type] => utility [patent_app_number] => 11/264046 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34258 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039915.pdf [firstpage_image] =>[orig_patent_app_number] => 11264046 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/264046
P-cadherin as a target for anti-cancer therapy Oct 31, 2005 Abandoned
Array ( [id] => 5813150 [patent_doc_number] => 20060083745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids' [patent_app_type] => utility [patent_app_number] => 11/254137 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 70491 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20060083745.pdf [firstpage_image] =>[orig_patent_app_number] => 11254137 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/254137
Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids Oct 18, 2005 Issued
Array ( [id] => 452790 [patent_doc_number] => 07247476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'Individualized anti-cancer antibodies' [patent_app_type] => utility [patent_app_number] => 11/241721 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6692 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247476.pdf [firstpage_image] =>[orig_patent_app_number] => 11241721 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/241721
Individualized anti-cancer antibodies Sep 29, 2005 Issued
Array ( [id] => 5720370 [patent_doc_number] => 20060073144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Individualized anti-cancer antibodies' [patent_app_type] => utility [patent_app_number] => 11/240787 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6615 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073144.pdf [firstpage_image] =>[orig_patent_app_number] => 11240787 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/240787
Individualized anti-cancer antibodies Sep 29, 2005 Abandoned
Array ( [id] => 5637480 [patent_doc_number] => 20060068453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Survivin, a protein that inhibits cellular apoptosis, and its modulation' [patent_app_type] => utility [patent_app_number] => 11/234308 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 25510 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20060068453.pdf [firstpage_image] =>[orig_patent_app_number] => 11234308 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/234308
Survivin, a protein that inhibits cellular apoptosis, and its modulation Sep 25, 2005 Abandoned
Array ( [id] => 5638051 [patent_doc_number] => 20060069025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Survivin, a protein that inhibits cellular apoptosis, and its modulation' [patent_app_type] => utility [patent_app_number] => 11/234225 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 25517 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069025.pdf [firstpage_image] =>[orig_patent_app_number] => 11234225 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/234225
Survivin, a protein that inhibits cellular apoptosis, and its modulation Sep 25, 2005 Abandoned
Array ( [id] => 7247282 [patent_doc_number] => 20050272092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Novel gene having reverse transcriptas motif' [patent_app_type] => utility [patent_app_number] => 11/199124 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7360 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272092.pdf [firstpage_image] =>[orig_patent_app_number] => 11199124 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/199124
Novel gene having reverse transcriptas motif Aug 8, 2005 Abandoned
Array ( [id] => 5747464 [patent_doc_number] => 20060110395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Use of CRKD as a breast cancer marker and cancer therapy target' [patent_app_type] => utility [patent_app_number] => 11/191457 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 31699 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110395.pdf [firstpage_image] =>[orig_patent_app_number] => 11191457 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/191457
Use of CRKD as a breast cancer marker and cancer therapy target Jul 27, 2005 Abandoned
Array ( [id] => 5045604 [patent_doc_number] => 20070264277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Compositions and Methods of Use for Mgd-Csf in Disease Treatment' [patent_app_type] => utility [patent_app_number] => 11/632319 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 53188 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264277.pdf [firstpage_image] =>[orig_patent_app_number] => 11632319 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/632319
Compositions and Methods of Use for Mgd-Csf in Disease Treatment Jul 20, 2005 Abandoned
Array ( [id] => 5630988 [patent_doc_number] => 20060147456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Induction of apoptosis in toll-like receptor expressing tumor cells' [patent_app_type] => utility [patent_app_number] => 11/184191 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12876 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147456.pdf [firstpage_image] =>[orig_patent_app_number] => 11184191 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/184191
Induction of apoptosis in toll-like receptor expressing tumor cells Jul 18, 2005 Abandoned
Array ( [id] => 6930779 [patent_doc_number] => 20050281813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins' [patent_app_type] => utility [patent_app_number] => 11/185567 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 24969 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281813.pdf [firstpage_image] =>[orig_patent_app_number] => 11185567 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/185567
Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins Jul 18, 2005 Abandoned
Array ( [id] => 7045560 [patent_doc_number] => 20050250155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Multiple marker characterization of single cells' [patent_app_type] => utility [patent_app_number] => 11/182897 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12036 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250155.pdf [firstpage_image] =>[orig_patent_app_number] => 11182897 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/182897
Multiple marker characterization of single cells Jul 17, 2005 Abandoned
Array ( [id] => 5766764 [patent_doc_number] => 20060018898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Antibody variants' [patent_app_type] => utility [patent_app_number] => 11/180631 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9174 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018898.pdf [firstpage_image] =>[orig_patent_app_number] => 11180631 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/180631
Antibody variants Jul 13, 2005 Issued
Array ( [id] => 5726891 [patent_doc_number] => 20060057651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/171567 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 24087 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057651.pdf [firstpage_image] =>[orig_patent_app_number] => 11171567 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/171567
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof Jun 29, 2005 Abandoned
Array ( [id] => 5865020 [patent_doc_number] => 20060099150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Compositions and methods for the transport of biologically active agents across cellular barriers' [patent_app_type] => utility [patent_app_number] => 11/169140 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 91064 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099150.pdf [firstpage_image] =>[orig_patent_app_number] => 11169140 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/169140
Compositions and methods for the transport of biologically active agents across cellular barriers Jun 26, 2005 Abandoned
Array ( [id] => 202977 [patent_doc_number] => 07632924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'Antigen-binding polypeptides and their uses' [patent_app_type] => utility [patent_app_number] => 11/155909 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 15 [patent_no_of_words] => 85936 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632924.pdf [firstpage_image] =>[orig_patent_app_number] => 11155909 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/155909
Antigen-binding polypeptides and their uses Jun 16, 2005 Issued
Array ( [id] => 7232885 [patent_doc_number] => 20050256049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Chimeric toxins for targeted therapy' [patent_app_type] => utility [patent_app_number] => 11/147360 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4724 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256049.pdf [firstpage_image] =>[orig_patent_app_number] => 11147360 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/147360
Chimeric toxins for targeted therapy Jun 7, 2005 Abandoned
Menu